Peter A. Jackman

Peter A. Jackman is a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. He effectively works with clients to identify IP opportunities and solve IP business challenges. His practice focuses on counseling clients in areas such as global patent portfolio procurement, management and enforcement strategies, technology transfer, invalidity, non-infringement, freedom-to-operate and patentability opinions and due diligence investigations. He has represented clients in patent reexaminations and inter partes review proceedings and has prosecuted patent applications domestically and internationally in areas such as immunology, genomics, molecular and cell biology, cell and gene therapy, recombinant DNA and fermentation technologies, transgenics, pharmaceutical formulations, bioprocessing, nutraceuticals, food science and industrial and agriculture biotechnologies such as advanced biofuels, bio-based chemicals and fertilizers, and molecular farming.

Peter is also a leader in the firm’s CleanTech Industry Group. He frequently lectures and publishes on intellectual property issues surrounding renewable technologies, and he was an associate editor for Clean Tech Law & Business, the first peer-reviewed journal devoted exclusively to the pursuit of environmentally sustainable technology. He serves as a Good Food Institute mentor to emerging alternative protein companies and served as a member of the BIO World Congress on Industrial Biotechnology Program Committee.

Additionally, Peter is a contributing author of Patent Office Litigation, Second Edition, published in 2017. The book provides a fresh and comprehensive exploration of patent office litigation proceedings, including how the proceedings interact with other aspects of patent procurement and enforcement, while delivering practical analysis and advice. This second edition of Patent Office Litigation is the follow up to the first version of the book that was published in 2012 by Thomson Reuters Westlaw that focused on the contested proceedings that were introduced under the America Invents Act that year.

Peter’s master’s thesis research was directed to hepatitis B virus X antigen and its relation in the development of chronic liver diseases. As a graduate student, he also co-authored a chapter entitled “Forensic Considerations in Environmental Pathology and Toxicology: Science, Regulation, Litigation, and a Tale of Two Toxins,” in 2 FORENSIC SCIENCES 31F-1 (Cyril H. Wecht ed., 1995).

During law school, Peter served as manuscripts editor of the University of Baltimore Intellectual Property Law Journal and published an article on the “Adoption of a First-to-File Patent System: A Proposal” for the University of Baltimore Law Review. He received his J.D. with concentrations in both Intellectual Property Law and Business Law.

Prior to joining the firm, Peter worked in the Office of Technology Development at the National Cancer Institute as a Technology Transfer Fellow. He has also been an adjunct professor at the University of Baltimore School of Law teaching a course in Technology Transfer.

Peter received his J.D., magna cum laude, from the University of Baltimore School of Law, his M.S. in microbiology from Thomas Jefferson University and his B.S. in biology from Villanova University.